Non-Hodgkin lymphoma (NHL) often develops in the lymph nodes and lymphatic tissue found in the stomach, intestines, or skin. NHL sometimes also affects the blood and bone marrow. The prognosis of NHL patients varies by type and by stage. However, ongoing lymphoma research and advances in treatment contribute to improved outcomes and quality of life.
Most patients are diagnosed by a hematologist, a doctor who specializes in blood cancers, such as lymphomas. Hematologists are also trained as cancer specialists called oncologists. The hematologists at Compass Oncology are experts in diagnosing and treating non-Hodgkin lymphoma. We will answer any questions you and your family have so you can better understand the details surrounding your specific diagnosis. We will also guide you through the entire treatment process.
Most patients with non-Hodgkin lymphoma present symptoms that are evaluated by the hematologist, followed by tests to confirm a diagnosis, including the subtype.
Non-Hodgkin lymphoma has more than 60 subtypes. The subtype of non-Hodgkin lymphoma is determined by several factors, including the type of blood cell the cancer started in. Understanding which subtype of NHL impacts the treatment options and the timing of when to give treatment.
Once a diagnosis of NHL is confirmed, hematologists must determine if it has spread and, if so, how much. This process of staging NHL will help determine the recommended treatments.
The specific treatment options included in your treatment plan and the timing of each is different for each patient. Learn more about commonly used treatments such as chemotherapy, immunotherapy, targeted therapy, and/or radiation therapy.